Page 38 - Clinical variability in Noonan syndrome with emphasison ear and eye
P. 38
CHAPTER 2
26. Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, Brunner HG, Bertola DR, Crosby A, Ion A, Kucherlapati RS, Jeffery S, Patton MA, Gelb BD. 2002. PTPN11 mutations in Noonan syndrome: Molecular spectrum genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 70:1555-1563.
27. Allanson JE, Hall JG, Hughes HE, Preus M, Witt RD. 1985. Noonan Syndrome: The changing phenotype. Am J Med Genet. 21:507-514.
28. Brasil AS, Malaquias AC, Wanderley LT, Kim CA, Krieger JE, Jorge AA, Pereira AC, Bertola DR. 2010. Co-occurring PTPN11 and SOS1 gene mutations in Noonan syndrome: does this predict a more severe phenotype? Arg Bras Endocrinol Metabol 54:717-722.
29. Ekvall S, Hagenas L, Allanson J, Annerén G, Bondeson ML. 2011. Co-occurring SHOC2 and PTPN11 mutations in a patient with severe/complex Noonan syndrome-like phenotype. Am J Med Genet A 155:1217-1224.
30. Serre D, Gurd S, Ge B, Sladek R, Sinnett D, Harmsen E, Bibikova M, Chudin E, Barker DL, Dickinson T, Fan JB, Hudson TJ. 2008. Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression. PLoS Genet 29:4(2).
36
